Total study population, No. |
1,275 |
432 |
5,742 |
|
Demographics |
|
|
|
|
Age, median [interquartile range], y |
67 [56, 77] |
67 [56, 78] |
68 [56, 81] |
.703 |
Male sex, No. (%) |
659 (52) |
222 (51) |
2,562 (45) |
.001 |
Black race, No. (%) |
243 (19) |
93 (22) |
1,139 (20) |
.671 |
Social and medical history, frequency (%) |
|
|
|
|
COPD |
657 (52) |
197 (46) |
2,621 (46) |
< .001 |
Renal disease |
523 (41) |
168 (39) |
1,494 (26) |
< .001 |
Diabetes mellitus |
473 (37) |
163 (38) |
1,797 (31) |
< .001 |
Congestive heart failure |
462 (36) |
173 (40) |
1,489 (26) |
< .001 |
Obese |
455 (36) |
149 (34) |
2,011 (35) |
.703 |
Current smoker |
459 (36) |
138 (32) |
1,746 (30) |
.073 |
Stroke |
184 (14) |
59 (14) |
713 (12) |
.671 |
Neoplastic disease |
164 (13) |
66 (15) |
760 (13) |
.703 |
Chronic renal failure |
131 (10) |
35 (8) |
362 (6) |
.143 |
HIV disease |
14 (1) |
6 (1) |
90 (2) |
< .001 |
Physical examination findings |
|
|
|
|
Altered mental status, No. (%) |
541 (42) |
80 (19) |
786 (14) |
< .001 |
Heart rate, median [interquartile range], beats/min |
115 [99, 131] |
110 [94, 124] |
103 [90, 116] |
< .001 |
Respiratory rate, median [interquartile range], breaths/min) |
29 [24, 35] |
24 [21, 28] |
22 [20, 24] |
< .001 |
Systolic BP, median [interquartile range], mm Hg |
97 [84, 118] |
112 [96, 133] |
119 [104, 137] |
< .001 |
Diastolic BP, median [interquartile range], mm Hg |
48 [40, 58] |
56 [46, 67] |
59 [51, 69] |
< .001 |
Temperature, median [interquartile range], degrees Celsius |
37 [37, 38] |
37 [37, 38] |
37 [37, 38] |
.703 |
Laboratory & radiographic findings, median [interquartile range] |
|
|
|
|
Hematocrit level, % |
35 [30, 40] |
34 [30, 39] |
36 [32, 40] |
< .001 |
Serum bicarbonate, mEq/L |
25 [21, 29] |
26 [22, 29] |
26 [24, 29] |
.186 |
BUN, mg/dL |
26 [16, 41] |
24 [15, 36] |
18 [12, 26] |
< .001 |
Serum glucose, mg/dL |
166 [131, 228] |
150 [118, 204] |
137 [111, 185] |
< .001 |
Serum sodium, mEq/L |
137 [133, 140] |
137 [133, 140] |
137 [134, 140] |
.466 |
Pleural effusion, frequency (%) |
480 (38) |
189 (44) |
1,738 (30) |
< .001 |
Ventilatory support and vasopressors, No. (%) |
|
|
|
|
Invasive mechanical ventilatory support |
394 (31) |
20 (5) |
15 (0) |
< .001 |
Noninvasive mechanical ventilatory support |
305 (24) |
41 (9) |
209 (4) |
< .001 |
Vasopressors |
186 (15) |
6 (1) |
21 (0) |
< .001 |